ATE442434T1 - Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate - Google Patents

Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate

Info

Publication number
ATE442434T1
ATE442434T1 AT03783222T AT03783222T ATE442434T1 AT E442434 T1 ATE442434 T1 AT E442434T1 AT 03783222 T AT03783222 T AT 03783222T AT 03783222 T AT03783222 T AT 03783222T AT E442434 T1 ATE442434 T1 AT E442434T1
Authority
AT
Austria
Prior art keywords
dendritic cells
transplant
intended
blood
immune system
Prior art date
Application number
AT03783222T
Other languages
English (en)
Inventor
Richard Leslie Edelson
Carole Berger
Michael Girardi
Original Assignee
Univ Yale School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale School Of Medicine filed Critical Univ Yale School Of Medicine
Application granted granted Critical
Publication of ATE442434T1 publication Critical patent/ATE442434T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/418—Antigens related to induction of tolerance to non-self
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03783222T 2002-11-08 2003-11-07 Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate ATE442434T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/290,802 US7727523B2 (en) 2001-08-13 2002-11-08 Method for suppressing immune system response to transplanted tissue or cells
PCT/US2003/035509 WO2004044149A2 (en) 2002-11-08 2003-11-07 Method for suppressing immune system response to transplanted tissue or cells

Publications (1)

Publication Number Publication Date
ATE442434T1 true ATE442434T1 (de) 2009-09-15

Family

ID=32312118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03783222T ATE442434T1 (de) 2002-11-08 2003-11-07 Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate

Country Status (8)

Country Link
US (2) US7727523B2 (de)
EP (2) EP1578958B1 (de)
AT (1) ATE442434T1 (de)
AU (2) AU2003290641B2 (de)
CA (1) CA2505527C (de)
DE (1) DE60329226D1 (de)
ES (2) ES2334501T3 (de)
WO (1) WO2004044149A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727523B2 (en) * 2001-08-13 2010-06-01 Yale University Method for suppressing immune system response to transplanted tissue or cells
ES2339752T3 (es) * 2001-08-13 2010-05-25 Yale University Metodo para inducir una respuesta inmune selectivamente suprimida.
WO2005027841A2 (en) * 2003-09-16 2005-03-31 University Of North Carolina At Chapel Hill Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
EP1951036A4 (de) * 2005-11-02 2009-05-27 Therakos Inc Verwendung von apoptotischen zellen ex vivo zur erzeugung von regulatorischen t-zellen
US8524495B2 (en) 2007-05-16 2013-09-03 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells
DK2318020T3 (en) 2008-06-30 2015-11-30 Universitätsklinikum Heidelberg Immunosuppressive blood cells and methods of producing same
US9399093B2 (en) 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
GB201300049D0 (en) * 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-stimulatory dendritic cells
GB201413665D0 (en) 2014-07-03 2014-09-17 Transimmune Ag And Yale University Method for obtaining globally activated monocytes
US10434240B2 (en) 2015-08-17 2019-10-08 Fenwal, Inc. Methods and systems for processing and washing a photopheresis mononuclear cell product
US20220214333A1 (en) * 2019-04-16 2022-07-07 Regents Of The University Of Minnesota Biomarker for transplantation tolerance induced by apoptotic donor leukocytes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321918A (en) 1979-10-23 1982-03-30 Clark Ii William T Process for suppressing immunity to transplants
US4838852A (en) 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
JP2000508628A (ja) 1996-03-22 2000-07-11 エール・ユニバーシティ 対象体内で免疫応答を誘導する方法
AU2872199A (en) 1998-02-20 1999-09-06 Rockefeller University, The Apoptotic cell-mediated antigen presentation to dendritic cells
AU768813B2 (en) 1998-03-30 2004-01-08 I.D.M. Immuno-Designed Molecules Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
US6540367B1 (en) * 1999-04-07 2003-04-01 3M Innovative Properties Company Structured surface articles containing geometric structures with compound faces and methods for making same
US20050084966A1 (en) * 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
EP1176986B1 (de) 1999-04-20 2018-07-04 Yale University Differenzierung von monozyten in funktionale dentritische zellen
US7560105B1 (en) * 1999-10-04 2009-07-14 Leids Universitair Medisch Centrum Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses
US6800300B1 (en) 2000-03-31 2004-10-05 Vasogen Ireland Limited Method for treating autoimmune and alloimmune diseases
AU2001253400B2 (en) * 2000-04-11 2007-03-01 University Of Southern California A method to prevent graft rejection using tgf-beta to induce t suppressor cells
CA2309518A1 (en) 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
US20050013810A1 (en) * 2001-05-08 2005-01-20 Waller Edmund K Regulating immune response using dendritic cells
AU2007200894B2 (en) * 2001-08-13 2009-10-29 Yale University Method for inducing selectively suppressed immune response
ES2339752T3 (es) * 2001-08-13 2010-05-25 Yale University Metodo para inducir una respuesta inmune selectivamente suprimida.
US7727523B2 (en) * 2001-08-13 2010-06-01 Yale University Method for suppressing immune system response to transplanted tissue or cells
US6602102B2 (en) 2001-10-10 2003-08-05 South Valley Specialties Buoyant silicone rubber compound

Also Published As

Publication number Publication date
US20030133914A1 (en) 2003-07-17
CA2505527A1 (en) 2004-05-27
EP2135942A1 (de) 2009-12-23
EP1578958B1 (de) 2009-09-09
EP1578958A4 (de) 2006-03-22
EP2135942B1 (de) 2012-08-08
WO2004044149A3 (en) 2004-07-15
US20100209409A1 (en) 2010-08-19
AU2010203292B2 (en) 2011-07-28
AU2010203292A1 (en) 2010-08-12
DE60329226D1 (de) 2009-10-22
CA2505527C (en) 2012-03-13
US7727523B2 (en) 2010-06-01
EP1578958A2 (de) 2005-09-28
WO2004044149A2 (en) 2004-05-27
ES2392842T3 (es) 2012-12-14
AU2003290641A1 (en) 2004-06-03
US8231868B2 (en) 2012-07-31
ES2334501T3 (es) 2010-03-11
AU2003290641B2 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
DE602004030823D1 (de) Verfahren und system zur herstellung von stammzellen aus fettgewebe
ATE442434T1 (de) Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate
MXPA02007137A (es) Fuente de tejido hepatico.
DK1294414T3 (da) Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
DE602005019064D1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
ATE413182T1 (de) Gerät und verfahren zur herstellung von stabilem langzeitigem thrombin aus plasma sowie so hergestelltes thrombin
WO2003013239A3 (de) Verfahren zur devitalisierung natürlicher organe und/oder zur bereitstellung extrazellulärer matrices zum 'tissue-engineering'
WO1998020932A3 (en) Conditioning for allogeneic stem cell transplantation
WO2009007531A3 (fr) Support collagenique modifie par greffage covalent de molecules d'adhesion
JP2018537472A (ja) 増殖造血幹細胞／前駆細胞集団の利用
WO2003085092A3 (en) Cellular transplantation for heart regeneration
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
WO2005047469A3 (en) PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
WO2010033598A3 (en) System and method for utilizing microbubbles and liposomes as viral sequestering agents
Siemionow et al. Impact of donor bone marrow on survival of composite tissue allografts
US20160120909A1 (en) Compositions And Methods For The Treatment Of Tinnitus
WO2004052305A3 (en) Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
Chen et al. A possible contribution of retinoids to regulation of fetal B lymphopoiesis
CN109810187A (zh) 一种动物蹄筋肌腱胶原蛋白的提取方法及应用
WO2008045528A3 (en) Methods and compositions for the treatment of cancer
EP1815856A3 (de) Krebsimpfstoff
EP1571204A1 (de) Leukozytenstimulations-Matrix
EP1728857A3 (de) Bereitstellung von Lebergewebe.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties